The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

as the wording of the ACIP’s recommendations will give the clearest view of how competitive the new shot will be in the US market. The CDC currently recommends pneumococcal vaccination for all ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Capvaxive be used to prevent invasive disease ...

The CDC justified the revised recommendation based on a change in the risk ... now is an ideal time to consider vaccination. Pneumococcal infections can also occur as a serious secondary infection ...

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal ...

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...

Advisory Committee on Immunization Practices (ACIP) has lowered the recommended age for pneumococcal vaccination from 65 to ...

Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

The CHMP’s recommendation will now be reviewed ... for more cases of IPD in adults compared to PCV20 (pneumococcal 20-valent conjugate vaccine): Data were included for select countries based ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the Committee for Medicinal Products ...